Kidney Cancer DNA Registry

Description

This registry will help us develop better methods of: * Preventing these cancers * Diagnosing these cancers * Treating these cancers

Conditions

Renal Cancer

Study Overview

Study Details

Study overview

This registry will help us develop better methods of: * Preventing these cancers * Diagnosing these cancers * Treating these cancers

Kidney Cancer DNA Registry

Kidney Cancer DNA Registry

Condition
Renal Cancer
Intervention / Treatment

-

Contacts and Locations

Basking Ridge

Memorial Sloan Kettering at Basking Ridge (Consent and Follow-up), Basking Ridge, New Jersey, United States, 07920

Middletown

Memorial Sloan Kettering Monmouth (Consent and Follow up), Middletown, New Jersey, United States, 07748

Montvale

Memorial Sloan Kettering Bergen (Consent and Follow up ), Montvale, New Jersey, United States, 07645

Commack

Memorial Sloan Kettering Commack (Consent and Follow-up), Commack, New York, United States, 11725

Harrison

Memorial Sloan Kettering Westchester (Consent and Follow up), Harrison, New York, United States, 10604

New York

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States, 10065

Uniondale

Memorial Sloan Kettering Nassau (Consent and Follow-Up), Uniondale, New York, United States, 11553

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Must be ≥ 18 years of age AND
  • * Must be an English-speaker AND
  • * Must have a diagnosis or suspicion of kidney cancer
  • * Must be ≥ 18 years of age AND
  • * Must be an English-speaker AND
  • * Must be a blood relative of the proband. Family members of probands including mother, father, sisters, brothers, half-sisters, half-brothers, daughters, sons, grandmothers, grandfathers, as well as aunts and uncles are eligible. These individuals need not have kidney cancer, as they will be used for segregation analysis of suspected variants found in the proband; requesting DNA from relatives is required.
  • * Must be ≥ 18 years of age AND
  • * Must be an English-speaker AND
  • * Must not have a personal history of cancer, with the exception of nonmelanoma skin cancer, AND
  • * Must not be a blood relative of any cases or controls enrolled in this study
  • * Patients who, in the opinion of the primary MSKCC clinician or the investigator, have a condition that precludes their ability to provide an informed consent

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Memorial Sloan Kettering Cancer Center,

Jonathan Jonathan, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

2026-03